Updated
July 10, 2026
People and health plans that overpaid for Mylan-branded and generic EpiPen and EpiPen Jr auto-injectors between 2011 and 2020 could share a $264 million fund — payments have been sent and claims are closed.
What's The EpiPen Settlement About?
Update: Epipen class action claimants have reported receiving emails that include payments upwards of $1,500 as of June 28, 2023. Payments were made in the form of a choice via a digital payment portal: virtual prepaid MasterCard, PayPal, direct deposit, or Venmo.As of A $264,000,000 settlement has been reached as a result of a lawsuit against certain manufacturers of EpiPens such as Mylan N.V., Mylan Specialty L.P., Mylan Pharmaceuticals Inc., Viatris Inc., or Heather Bresch. The Epipen Class Action Settlement is officially closed to new claims. The administrator provided the following update:
Since the Epipen class action is closed to new claims, and has received final approval from the judge, the distribution of payments process for eligible claimants is expected start in June 2023. When the distribution is prepared to begin, consumers with a valid claim will receive an initial email at the email address they provided on the Claim Form. This email will contain instructions on how to redeem their payment through a digital payment process, after which payments will be sent out. Digital payouts are stated to occur between June 14 and June 19, 2023. Please look for a payment email from the settlement administrator if you qualified for the Epipen class action settlement — more information is available on the official settlement website.
Following the initial email, a second email will be sent to claimants, which will include a live link to redeem the digital payment, as well as information regarding the payment amount. It is important to note that details about the payment amounts will only be available once the second email has been received by the claimant who qualified for payment.
*Please note that this Epipen junior settlement is different from a previous EpiPen settlement against Pfizer manufacutured EpiPens which resulted in an even larger $345M class action settlement. The lawsuit alleged that EpiPen manufacturers violated certain state antitrust, federal racketeering, and other laws in the United States, harming competition and causing Class Members to overpay for their products. Mylan and the Pfizer Defendants are liable for violations of certain state antitrust laws and federal racketeering laws in the United States, harming competition and causing Class Members to overpay for:
• EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors;
• EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors, Epinephrine Injections;
• USP Auto-Injectors (the authorized generic for EpiPen®) (collectively, “EpiPen” products).
Mylan denied that it violated but agreed to create a $264,000,000 settlement fund.
Status
Payments Sent
Closed to new claims — digital payouts distributed
Claim Deadline
Passed
Settlement Fund
$264,000,000
Mylan EpiPen antitrust class · pro rata cash
Proof Required
No
How Do I Qualify?
The Court has certified the following members as qualifying for part of the $264 Million Settlement fund:• Any people or entities in the United States who paid or provided reimbursement for some or all of the purchase price of Branded or authorized generic EpiPens for the purpose of consumption, and not resale, by themselves, their family member(s), insureds, plan participants, employees, or beneficiaries, at any time between August 24, 2011, and November 1, 2020; and
• Those in the Antitrust States (listed below) who paid or provided reimbursement for some or all of the purchase price of Branded EpiPens at any time between January 28, 2013, and November 1, 2020, for the purpose of consumption, and not resale, by themselves, their family member(s), insureds, plan participants, employees, or beneficiaries
• The “Antitrust States” are as follows: Alabama, California, Florida, Hawaii, Illinois, Kansas, Maine, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New York, North Carolina, Tennessee, and Utah.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Filing Class Action Settlement Claims
Please note that your claim form will be rejected if you submit a settlement claim for payout with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. You would also be harming others that actually qualify for the class action settlement. If you are not sure whether or not you qualify for this class action settlement, visit the class action administrator's website below. OpenClassActions.com is only providing information and is not a class action administrator or a law firm. OpenClassActions is a participant in the Amazon affiliate advertising program and this post may contain affiliate links, which means we may earn a commission or fees if you make a purchase via those links.
For more class actions keep scrolling below.
